Abstract | BACKGROUND: PROCEDURE: RESULTS: CONCLUSIONS: The preliminary results in phase I trials of solid tumors in children and the results of this study suggest that paclitaxel in phase II studies can now be entertained for patients with hepatoblastoma.
|
Authors | J Fuchs, G Habild, I Leuschner, D V Schweinitz, J Haindl, E Knop |
Journal | Medical and pediatric oncology
(Med Pediatr Oncol)
Vol. 32
Issue 3
Pg. 209-15
(Mar 1999)
ISSN: 0098-1532 [Print] United States |
PMID | 10064189
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies
- Antineoplastic Agents, Phytogenic
- Tubulin
- alpha-Fetoproteins
- Paclitaxel
|
Topics |
- Animals
- Antibodies
(chemistry)
- Antineoplastic Agents, Phytogenic
(pharmacology)
- Cell Division
(drug effects)
- Child, Preschool
- Disease Models, Animal
- Female
- Hepatoblastoma
(chemistry, drug therapy, pathology, ultrastructure)
- Humans
- Immunohistochemistry
- Infant
- Liver Neoplasms
(chemistry, drug therapy, pathology, ultrastructure)
- Mice
- Mice, Nude
- Paclitaxel
(pharmacology)
- Transplantation, Heterologous
- Tubulin
(immunology)
- alpha-Fetoproteins
(metabolism)
|